FREE Account Opening + No Clearing Fees
Loading...

Maiden Forgings IPO vs Sotac Pharmaceuticals IPO

Comparision between Maiden Forgings IPO and Sotac Pharmaceuticals IPO.

IPO Details

Maiden Forgings IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
Logo Maiden Forgings IPO Logo Sotac Pharmaceuticals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Share India Capital Services Private Limited Beeline Capital Advisors Pvt Ltd
Registrar Maashitla Securities Private Limited Kfin Technologies Limited
Market Maker Share India Securities Limited Sunflower Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Maiden Forgings IPO is up to ₹23.84 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of Maiden Forgings IPO is ₹63.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹60.00 per share ₹105.00 per share
Issue Price (Upper) ₹63.00 per share ₹111.00 per share
Issue Price (Final) ₹63.00 per share ₹111.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 1200 shares
Fresh Issue Size 37,84,000 shares 30,00,000 shares
Fresh Issue Size (Amount) up to ₹23.84 Cr up to ₹33.30 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 37,84,000 shares 30,00,000 shares
Issue Size Total (Amount) up to ₹23.84 Cr up to ₹33.30 Cr

IPO Timetable

Maiden Forgings IPO opens on Mar 23, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Maiden Forgings IPO and Sotac Pharmaceuticals IPO is Mar 27, 2023, and Apr 03, 2023, respectively.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
Anchor Bid Date Mar 22, 2023 Mar 28, 2023
Issue Open Mar 23, 2023 Mar 29, 2023
Issue Close Mar 27, 2023 Apr 03, 2023
Basis Of Allotment (Tentative) Mar 31, 2023 Apr 10, 2023
Initiation of Refunds (Tentative) Apr 03, 2023 Apr 11, 2023
Credit of Share (Tentative) Apr 05, 2023 Apr 12, 2023
Listing date (Tentative) Apr 06, 2023 Apr 13, 2023
Anchor Lockin End date 1 Apr 30, 2023 May 10, 2023
Anchor Lockin End date 2 Jun 29, 2023 Jul 09, 2023

Financials

Maiden Forgings IPO P/E ratio is 8.38, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
Financial
Maiden Forgings Limited Financial Information (Restated Standalone)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-209,890.0520,440.37165.952,136.921,672.025,788.13
31-Mar-2110,484.2519,937.49168.942,899.112,377.715,428.93
31-Mar-2211,014.2321,083.72213.943,113.052,591.656,170.75
31-Dec-2212,595.6916,381.04801.513,914.562,871.766,525.17
Amount in ₹ Lakhs
Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-203,038.212,882.648.75305.7375.7315.13
31-Mar-213,469.754,894.97-236.54249.3619.361,035.80
31-Mar-223,525.357,337.02287.86662.19432.191,134.59
30-Sep-226,461.603,994.6546.55797.41567.412,185.52
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 100% 84.63%
Promoter Shareholding (Post-Issue) 73.37%
P/E Ratio 8.38 132.14
Market Cap ₹89.54 Cr. ₹122.66 Cr.
ROE 6.38%%
ROCE 19.03%%
Debt/Equity 2.74
EPS
RoNW

Shares Offered

In the Maiden Forgings IPO retail investors (RII) are offered 22,64,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 22,64,000 shares. Qualified institutional buyers (QIB) are offered 3,60,000 shares in Maiden Forgings IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
Anchor Investor Reserveration 8,53,200 shares
Market Maker Reserveration 1,90,000 shares 1,50,000 shares
QIB 3,60,000 shares 5,71,800 shares
NII 9,70,000 shares 4,28,400 shares
RII 22,64,000 shares 9,98,400 shares
Employee 0 shares 0 shares
Others
Total 37,84,000 shares 19,98,600 shares

Bids Received (Subscription)

Maiden Forgings IPO subscribed 1.20x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.

  Maiden Forgings IPO Sotac Pharmaceuticals IPO
QIB (times) 1.00x 1.00x
NII (times) 1.42x 4.04x
Big NII (times)
Small NII (times)
RII (times) 1.12x 0.91x
Employee (times)
Other (times)
Total (times) 1.20x 1.60x

Comments

Add a public comment...